Tag

Ilya Pharma

Evelina Vågesjö Photo Jenny Öhman Nordic Life Science

Ilya Pharma extends global patent coverage

May 25, 2022

Ilya Pharma has announced that …

Board

Ilya Pharma appoints corporate development specialists

May 5, 2022

Ilya Pharma has announced the …

Ilya Pharma announces FDA clearance of IND

May 4, 2022

Ilya Pharma has announced that …

Evelina Vågesjö Photo Jenny Öhman Nordic Life Science

Ilya Pharma makes strategic investment in bioanalytical company

April 20, 2022

Ilya Pharma has made a …

Evelina Vågesjö

Ilya Pharma closes 8.5 million EUR funding round

March 17, 2022

Ilya Pharma has closed a …

Evelina Vågesjö Photo Jenny Öhman Nordic Life Science

Ilya Pharma to submit an IND for a Phase 1/2a study

January 12, 2022

Ilya Pharma is planning to …

Oskar Lund

Ilya Pharma appoints new CFO in preparation for IPO

August 23, 2021

Ilya Pharma has announced that …

Evelina Vågesjö Photo Jenny Öhman Nordic Life Science

Ilya Pharma to initiate Phase II clinical trial

June 30, 2021

The company has received approval …

Evelina Vågesjö included in a 2021 Power List in Advanced therapies

April 21, 2021

The CEO of Ilya Pharma, …

Ilya Pharma awarded European patent

February 3, 2021

Ilya Pharma has announced that …

Evelina Vågesjö

Positive results from Ilya’s Phase I trial

January 14, 2021

Ilya Pharma has announced positive …

Evelina Vågesjö

Evelina Vågesjö: ”I want to see my work go beyond the lab”

Ellen R. Delisio

January 7, 2021

What began as a project …

Evelina Vågesjö

Ilya Pharma extends research collaboration with Uppsala University

December 28, 2020

Ilya Pharma has signed a …

Evelina Vågesjö

Ilya Pharma completes patient recruitment in first-in-human Phase I trial

October 13, 2020

Ilya Pharma has completed recruitment …

Evelina Vågesjö

Ilya Pharma awarded US Utility Patent

September 2, 2020

Ilya Pharma has announced that …

Evelina Vågesjö

Ilya Pharma selected for Springboard’s Health Innovation Hub

June 4, 2020

Ilya Pharma is one of …